Zinger Key Points
- Intuitive Surgical plans to acquire da Vinci and Ion distribution businesses in Southern Europe, expected to close in 2026.
- CEO Gary Guthart emphasizes the importance of direct presence in Italy, Spain, Portugal, Malta, and San Marino to better serve customers.
- Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings—Live With Chris Capre on Wednesday, June 11.
On Tuesday, Intuitive Surgical, Inc. ISRG announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories.
The acquisition, subject to regulatory approvals, will expand Intuitive’s direct presence in these regions, with the transaction expected to close in 2026.
Intuitive has entered into an agreement with its current distributors, ab medica, Abex, and Excelencia Robotica, to purchase their Intuitive product-related business.
Once the deal is finalized, the acquired businesses will be fully integrated into Intuitive’s European operations, led by Senior Vice President and General Manager Dirk Barten.
CEO Gary Guthart expressed excitement about the opportunity to bring minimally invasive care to more patients across Europe. He highlighted the importance of having a direct presence in these countries to better understand the unique needs of customers.
- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
“Having a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories allows us to deepen our understanding of unique customer needs in these countries,” Guthart added.
Francesca Cerruti, CEO of ab medica, emphasized their long history of introducing robotic-assisted surgery in Southern Europe.
According to Benzinga Pro, ISRG stock has gained over 62% in the past year. Investors can gain exposure to the stock via Spinnaker ETF Series Langar Global HealthTech ETF LGHT.
Price Action: ISRG shares are trading higher by 1.03% to $610.33 at last check Wednesday.
Read Next:
Photo via Shutterstock.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.